State of the Art series on drug-resistant tuberculosis: it's time to protect fluoroquinolones

Int J Tuberc Lung Dis. 2009 Nov;13(11):1319.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Drug Resistance, Multiple, Bacterial* / genetics
  • Extensively Drug-Resistant Tuberculosis / drug therapy*
  • Extensively Drug-Resistant Tuberculosis / microbiology
  • Extensively Drug-Resistant Tuberculosis / transmission
  • Fluoroquinolones / therapeutic use*
  • Genotype
  • Humans
  • Mutation
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / genetics
  • Mycobacterium tuberculosis / pathogenicity
  • Phenotype
  • Practice Guidelines as Topic
  • Treatment Failure
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • Tuberculosis, Multidrug-Resistant / microbiology
  • Tuberculosis, Multidrug-Resistant / transmission
  • Virulence

Substances

  • Antitubercular Agents
  • Fluoroquinolones